Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
FP6Докторантска мрежа2005–2009

ARDIS · Autoimmunity and rheumatic disease research groups

6РП — Действия „Мария Кюри“

Период
2005-07-01 → 2009-06-30
Финансиране от ЕС
1 714 390 €
Участници
6
Схема
EST

Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.

Накратко на български

Генетичните маркери и механизмите на автоимунни заболявания като ревматоиден артрит и множествена склероза се анализират чрез човешки и мишани модели. Това помага за по-доброто разбиране на причините за тези болести, което е основа за подобряване на тяхната диагностика и лечение.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Final Activity Report Summary - ARDIS (Autoimmunity and rheumatic disease research groups)

Research groups in autoimmunity at the Universities of Bergen, Lund / Karolinska Institute, Erlangen / Frankfurt and Oxford have provided early stage training for nine PhD students in immunology, genetics and molecular medicine of Rheumatoid arthritis (RA), Sjögren's syndrome (SS) and Multiple sclerosis (MS). This training was based on a broad integrated approach with the aim of initiating a better understanding of the immunopathogenesis and genetic background of autoimmune diseases in general. The long-term objectives was to reach a more fundamental basis for better diagnosis and treatment in these chronic, disabling and enigmatic diseases affecting a large part of the European population. The area of research training was autoimmune reactions, disease mechanisms and genetics with basis in both human and murine model systems. The exploration of genetic markers of these autoimmune diseases was seen as an integral part of making progress in understanding; it provided vital clues to focus immunological studies in the future leading to intervention in RA, SS and MS and pointing the way forward for other similar diseases. In short, the PhD trainees were confronted with the following aspects during training: -characterisation of the target structures of autoimmune responses for an improvement of diagnostic tools and eventually the development of antigen-specific immunomodulatory strategies; - positional cloning of genes responsible for animal model diseases corresponding to human RA, MS and SS; - in depth studies on the pathogenic pathways leading to RA, MS and SS, primarily using congenic and specifically mutated strains; - establishment and studies of humanised mice. These mice are humanized with the human homologous genes identified in the animal models like MHC class II and type II collagen; - establishment of a higher plateau in the knowledge base and enhanced treatment strategies that can be applied, in whole or in part, to other autoimmune diseases.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

AUTOIMMUNITY research groups at the Universities of Bergen, Lund, Erlangen and Oxford will offer earlystage training in immunology, genetics and molecular medicine of rheumatoid arthritis (RA), Sjogren'ssyndrome (SS) and multiple sclerosis (MS). This train ing is based on a broad integrated disciplinary approachwith the aim of initiating a better understanding of the common features of the immunopathogenesis andcommon genetic background of autoimmune diseases in general. The long-term objectives are to reach a morefundamental basis for better diagnosis and treatment in these chronic, disabling and enigmatic diseases affectinga large part (5-6 mill.) of the European population. The area of research training is autoimmune reactions,disease mechanisms and geneti cs with basis in both human and murine model systems. By using severalcomplementary strategies this European training intends to reveal a picture of molecular, genetic and clinicalmarkers for the diagnosis and progression of RA, SS and MS. It will do so by analysing the complexmechanisms by which organ-specific inflammation of RA, SS and MS develops and persists. The exploration ofgenetic markers of these autoimmune diseases is seen as a new and integral part of making progress inunderstanding; it will prov ide vital clues to focus immunological studies in the future leading to directintervention in RA, SS and MS and pointing the way forward for other similar diseases. The nature of thetraining activities in the form of prospective and genetic studies over ma ny years including also clinical studies isa guarantee for the long-term activity.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз